Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 223 of 223 entries
View as:

Efficacy and Safety Study for Subjects With Mild-to-Moderate Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00948909 Org: User:
Start: 10/31/09 End: 11/30/10 Due: 11/30/11

A Trial of ABT-888 in Combination With Temozolomide Versus Pegylated Liposomal Doxorubicin Alone in Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01113957 Org: User:
Start: 03/31/10 End: 06/30/13 Due: 06/30/14

Open Label Continuation Study in Moderate to Severe Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT00626002 Org: User:
Start: 02/29/08 End: 10/31/11 Due: 10/31/12

Effectiveness of Adalimumab in Moderate to Severe Plaque Psoriasis Patients With Distinct Co-morbidities

Phase: N/A Priority: Normal
NCT ID: NCT01401452 Org: User:
Start: 08/31/11 End: 05/31/16 Due: 05/31/17

Study of Efficacy, Safety and Tolerability of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00357994 Org: User:
Start: 01/31/09 End: 10/31/11 Due: 10/31/12

Safety and Efficacy Study in Subjects With Diabetic Neuropathic Pain

Phase: N/A Priority: Normal
NCT ID: NCT00507936 Org: User:
Start: 08/31/07 End: 10/31/08 Due: 10/31/09

Study of Efficacy, Safety and Tolerability of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00660387 Org: User:
Start: 12/31/09 End: 10/31/11 Due: 10/31/12

Safety and Effectiveness of Two Doses of ABT-874 as Compared to Placebo in Subjects With Multiple Sclerosis (MS)

Phase: N/A Priority: Normal
NCT ID: NCT00086671 Org: User:
Start: 04/30/04 End: 11/30/06 Due: 11/30/07

Safety of Lopinavir/Ritonavir (Kaletra) in HIV/HCV Co-infected Subjects vs Baseline Liver Biopsy Metavir Score

Phase: N/A Priority: Normal
NCT ID: NCT00234975 Org: User:
Start: 10/31/02 End: 01/31/08 Due: 01/31/09

Open-label Extension Study of Navitoclax in Subjects With Chronic Lymphocytic Leukemia (CLL)

Phase: N/A Priority: Normal
NCT ID: NCT01557777 Org: User:
Start: 06/30/12 End: 07/31/13 Due: 07/31/14

A Study to Evaluate ABT-126 for the Treatment of Cognitive Deficits in Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT01655680 Org: User:
Start: 05/31/12 End: 07/31/14 Due: 07/31/15

Efficacy and Safety Study of Adalimumab in the Treatment of Hidradenitis Suppurativa

Phase: N/A Priority: Normal
NCT ID: NCT01468233 Org: User:
Start: 11/30/11 End: 04/30/14 Due: 04/30/15

A Prospective, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate Efficacy and Safety of Atrasentan, Including Thoracic Bioimpedance, in Type 2 Diabetic Subjects With Nephropathy

Phase: N/A Priority: Normal
NCT ID: NCT01399580 Org: User:
Start: 08/31/11 End: 09/30/12 Due: 09/30/13

A Study to Evaluate Chronic Hepatitis C Infection in Treatment Experienced Adults

Phase: N/A Priority: Normal
NCT ID: NCT01715415 Org: User:
Start: 11/30/12 End: 10/31/14 Due: 10/31/15

Observational Program to Assess Routine Use of Add-back Therapy in Patients With Endometriosis in Russian Federation, Planned for 6-month Course of Lucrin Depot® (Leuprorelin)

Phase: N/A Priority: Normal
NCT ID: NCT01294371 Org: User:
Start: 02/28/11 End: 05/31/12 Due: 05/31/13

Surveillance of Synagis in Korean Pediatric Patients

Phase: N/A Priority: Normal
NCT ID: NCT01537198 Org: User:
Start: 01/31/12 End: 06/30/14 Due: 06/30/15

A Study of Rheumatoid Arthritis Patients on Adalimumab to Evaluate Quality of Life Variables, Effects on Work Productivity and Functional Outcomes in Malaysia

Phase: N/A Priority: Normal
NCT ID: NCT01387789 Org: User:
Start: 08/31/11 End: 03/31/13 Due: 03/31/14

Efficacy and Safety Study of Adalimumab in Treatment of Hidradenitis Suppurativa

Phase: N/A Priority: Normal
NCT ID: NCT01468207 Org: User:
Start: 11/30/11 End: 01/31/14 Due: 01/31/15

Comparison of Efficacy and Safety of Paricalcitol Injection With Maxacalcitol Injection in Adult Japanese Chronic Kidney Disease Subjects Receiving Hemodialysis With Secondary Hyperparathyroidism

Phase: N/A Priority: Normal
NCT ID: NCT01341782 Org: User:
Start: 05/31/11 End: 04/30/12 Due: 04/30/13

Study to Evaluate the Safety and Efficacy of ABT-712 in Subjects With Moderate to Severe Chronic Low Back Pain (CLBP)

Phase: N/A Priority: Normal
NCT ID: NCT00761150 Org: User:
Start: 09/30/08 End: 03/31/09 Due: 03/31/10

Efficacy and Safety of Adalimumab in Patients With Rheumatoid Arthritis in Routine Clinical Practice

Phase: N/A Priority: Normal
NCT ID: NCT01077258 Org: User:
Start: 04/30/04 End: 02/28/13 Due: 02/28/14

A 3-year Study Following up Patients With Moderate to Severe Rheumatoid Arthritis Treated With Humira in Greece

Phase: N/A Priority: Normal
NCT ID: NCT01086033 Org: User:
Start: 05/31/06 End: 07/31/12 Due: 07/31/13

Evaluation of Treatment With Zemplar Capsules in the Therapy of Secondary Hyperparathyroidism (SHPT)

Phase: N/A Priority: Normal
NCT ID: NCT01224782 Org: User:
Start: 10/31/10 End: 08/31/13 Due: 08/31/14